Updated on March 9, 2026 by Lori Mulligan, MPH. To give you technically accurate, evidence-based information, content published on the Everlywell blog is reviewed by credentialed professionals with expertise in medical and bioscience fields.
Everlywell works with preferred partners. If you click on links or make a purchase through this page, we may earn a commission.
If you're thinking about starting Wegovy®, you may be wondering what dose treatment begins with and how it increases over time. Wegovy® dosing starts low and is gradually increased so your body can adjust to the medication.
The recommended starting dose of Wegovy® (semaglutide) is 0.25 mg injected once weekly. This initial dose is typically taken for the first four weeks of treatment. Starting with a lower dose helps reduce the risk of gastrointestinal side effects such as nausea or vomiting while your body adjusts to the medication.[2]
After the first four weeks, healthcare providers typically increase the dose gradually according to a dose-escalation schedule. This step-up approach is recommended in the prescribing information to help improve tolerability as patients move toward the maintenance dose used for long-term weight management.[2]
What Is the Starting Dose of Wegovy®?
The recommended starting dose of Wegovy® (semaglutide) is 0.25 mg injected once weekly. This initial dose is typically taken for the first four weeks of treatment. The lower starting dose helps the body adjust to the medication and may reduce the likelihood of gastrointestinal side effects such as nausea or vomiting. [2]
After the first four weeks, healthcare providers usually increase the dose gradually according to a dose-escalation schedule. This step-up approach is recommended in the prescribing information to help improve tolerability as patients move toward the maintenance dose used for long-term weight management. [2]
What Is the Typical Dosing Schedule for Wegovy®?
Wegovy® is typically started at a low dose and gradually increased over several weeks. This process, called dose escalation, helps the body adjust to the medication and may reduce gastrointestinal side effects. According to the prescribing information, the dose is increased about every four weeks until the maintenance dose is reached.[2]
| Treatment Phase | Weekly Dose | Duration |
|---|---|---|
| Starting dose | 0.25 mg | Weeks 1–4 |
| Dose escalation | 0.5 mg | Weeks 5–8 |
| Dose escalation | 1 mg | Weeks 9–12 |
| Dose escalation | 1.7 mg | Weeks 13–16 |
| Maintenance dose | 2.4 mg | Week 17 and beyond |
Your healthcare provider may adjust the dosing schedule depending on how well you tolerate the medication or if side effects occur. Wegovy® is administered as a once-weekly injection on the same day each week, with or without food.
What to Do if You Miss a Dose
- If you miss a dose of Wegovy® and your next scheduled dose is more than 48 hours away, take the missed dose as soon as possible.
- If your next scheduled dose is less than 48 hours away, skip the missed dose and take your next dose at the regular time.
- If you miss Wegovy® doses for more than two weeks, contact your healthcare provider to discuss how to restart treatment.
The most common side effects reported with Wegovy® include nausea, diarrhea, vomiting, constipation, abdominal pain, headache, fatigue, bloating, gas, and heartburn.
If nausea occurs after starting Wegovy®, healthcare providers often recommend strategies such as eating smaller meals, choosing low-fat foods, eating slowly, staying hydrated, and avoiding lying down immediately after eating.[2]
Wegovy® vs. Ozempic®
Another medication that has received significant attention is Ozempic®. While Ozempic® is FDA-approved for the treatment of type 2 diabetes, it is sometimes prescribed off-label for weight management.
Both Wegovy® and Ozempic® contain the same active ingredient, semaglutide, and belong to the GLP-1 receptor agonist class of medications. One key difference between the two drugs is dosage. Wegovy® is prescribed at higher doses for weight management compared with Ozempic®.
GLP-1 medications work by stimulating insulin release when blood sugar levels rise after eating. They also slow gastric emptying and influence appetite signals in the brain. These effects can help people feel full sooner and for longer periods of time, which may lead to reduced food intake.
In addition to supporting weight loss and blood sugar control, some GLP-1 medications may provide additional cardiovascular benefits. Research suggests certain drugs in this class may reduce the risk of heart disease, stroke, and kidney disease, though it remains unclear whether these benefits are due to the medication itself or the associated weight loss.
Like any medication, GLP-1 drugs can cause side effects. The most common include:
- Nausea
- Vomiting
- Diarrhea
Low blood sugar (hypoglycemia) is a more serious risk but usually occurs only when GLP-1 medications are taken alongside other diabetes medications such as insulin or sulfonylureas.
GLP-1 medications are not recommended for individuals with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome. They are also generally avoided in people with a history of pancreatitis.[3]
Exploring Treatment Options
If you’re considering medications such as Wegovy® or Ozempic®, working with a healthcare provider can help you understand which options may be appropriate for your health goals.
A clinician can review your medical history, discuss potential risks and benefits, and determine whether GLP-1 medications may be suitable for your needs.
Some individuals choose to explore telehealth weight management programs that connect patients with licensed providers who can evaluate eligibility for medications like semaglutide and provide ongoing guidance.
Related Content
Wegovy® Weight Loss Results: What to Know
How Long Do You Take Wegovy® for Weight Loss?
Wegovy® vs. Ozempic®: Explaining These Medications
References
- Jurgensen Julia. Expert Opinion: What is up with Wegovy®? https://connect.mayoclinic.org/blog/weight-management-1/newsfeed-post/expert-opinion-what-is-up-with-wegovy. January 7, 2022. Accessed on July 17, 2023.
- Wegovy® dosing schedule for adults. Wegovy®. https://www.wegovy.com/taking-wegovy/dosing-schedule.html. Accessed on July 17, 2023.
- GLP-1 agonists: Diabetes drugs and weight loss. Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/type-2-diabetes/expert-answers/byetta/faq-20057955. Accessed on July 17, 2023.
Spotlight on
Featured content
Explore Everlywell
